Jinxin Fertility Group Ltd
HKEX:1951
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.09
4.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Jinxin Fertility Group Ltd
Jinxin Fertility Group Ltd
Total Equity
Jinxin Fertility Group Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jinxin Fertility Group Ltd
HKEX:1951
|
Total Equity
¥10.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Equity
¥7.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Total Equity
¥3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Equity
¥17.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Equity
¥7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
28%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Equity
¥7.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
35%
|
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd., a prominent player in the assisted reproduction market, has woven its narrative into the tapestry of modern healthcare by addressing a universal yet profoundly personal concern—fertility. Headquartered in China, this company has emerged at the forefront of fertility services, providing a comprehensive suite of offerings that include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and frozen embryo transfer (FET), among other reproductive technologies. Operating in a market driven by societal shifts such as later-life family planning and increased urbanization, Jinxin Fertility has positioned itself strategically to capitalize on the growing demand for fertility treatments. Through its vast network of clinics across China and in key locations overseas, the company draws a diverse clientele seeking advanced reproductive assistance. What distinguishes Jinxin Fertility Group in this competitive landscape is its blend of cutting-edge technology and high-quality medical expertise. The company invests heavily in research and development to enhance its medical processes, ensuring high success rates and customer satisfaction. This approach not only solidifies its reputation as a trusted provider of fertility solutions but also translates into substantial profitability as clients are willing to invest in reliable and effective treatments for the chance at parenthood. Revenue streams flow from several channels, with core earnings derived from treatment and consultation fees, while ancillary services like genetic testing and cryopreservation contribute additional income. This multifaceted business model not only reinforces Jinxin Fertility’s financial robustness but also underscores its commitment to supporting hopeful parents through every step of their fertility journey.
See Also
What is Jinxin Fertility Group Ltd's Total Equity?
Total Equity
10.1B
CNY
Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Total Equity amounts to 10.1B CNY.
What is Jinxin Fertility Group Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
18%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Jinxin Fertility Group Ltd have been 11% over the past three years , 18% over the past five years .
You don't have any saved screeners yet